Inactief instrument

Andere talen Akers Biosciences Inc Nasdaq

Aandelen

US00973E1029

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

MyMD Pharmaceuticals : Modification to Rights of Security Holders Form 8 K	24/06
MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer	17/06
MyMD Pharmaceuticals, Inc. Announces Management Changes	17/06
MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc.	17/06
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers	03/06
MyMD Pharmaceuticals : Modification to Rights of Security Holders - Form 8-K	23/05
MyMD Pharmaceuticals, Inc. amended terms of the transaction	23/05
MyMD Pharmaceuticals : Secures Strategic Investments - Form 8-K	21/05
MyMD Pharmaceuticals Secures Strategic Investments	21/05
MyMD Pharmaceuticals, Inc. announced that it expects to receive $14 million in funding from PharmaCyte Biotech, Inc.	20/05
MyMD Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
MyMD Pharmaceuticals, Inc. Announces Resignation of Adam Kaplin as Chief Scientific Officer	18/04
Ladenburg Thalmann, Esteemed Wall Street Long-Standing Stalwart Since 1876, Advocates 'Buy' for Intelligent Bio, Precision Bio, and More: VTAK, INBS, LASE, MYMD, RVSN	10/04
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data	09/04
Investors Eye Wednesday Inflation Data as US Futures Tread Water Tuesday Pre-Bell	09/04
Top Premarket Gainers	09/04
MyMD Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
MyMD Pharmaceuticals Regains Compliance With Nasdaq's Minimum Bid Listing Requirement	05/03
MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing	05/03
MyMD Pharmaceuticals to Implement 1-for-30 Reverse Stock Split	13/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Akers Biosciences Inc Nasdaq

Aandelen

US00973E1029

Andere talen

Filters